Optometrist · Sparks, NV
NPI
1326323478
Since 2011
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
670 N McCarran Blvd
Sparks, NV, 89431
Phone (775) 358-1317
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
777 services
Medicare patients, 2024
341
Average age 74
Drug cost, 2024
$154K
563 prescriptions
Company payments, 2025
$271
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mackenzie Macintyre III was code 92014 (ophthalmological e&m), 180 times for 180 patients. In total Mackenzie Macintyre III billed 777 services in 17 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 180 | 180 | $80.64 | $15K |
| 99213 Office E&M - Established | Office | 177 | 110 | $60.78 | $11K |
| 92004 Ophthalmological E&M | Office | 87 | 87 | $83.52 | $7,266 |
| 92250 Angiography | Office | 70 | 63 | $24.68 | $1,728 |
| 92134 Computerized Ophthalmic Imaging | Office | 62 | 47 | $24.81 | $1,538 |
| 99214 Office E&M - Established | Office | 61 | 54 | $77.67 | $4,738 |
| 92133 Computerized Ophthalmic Imaging | Office | 40 | 39 | $21.54 | $862 |
| 92083 Vision, Hearing, and Speech Services | Office | 34 | 30 | $37.83 | $1,286 |
| 66984 Cataract Surgery | Office | 26 | 14 | $72.39 | $1,882 |
By year: 2022 $25K for 397 services; 2023 $39K for 610 services; 2024 $52K for 777 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mackenzie Macintyre III prescribed most often to Medicare patients was Azelastine Hcl, with 114 prescriptions and refills. In total Mackenzie Macintyre III wrote 563 Medicare prescriptions that cost $154K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 114 | 155 | 59 | $3,463 |
| Epinastine Hcl Generic | 96 | 133 | 53 | $5,450 |
| Latanoprost Generic | 70 | 133 | 21 | $864 |
| Cyclosporine Generic | 38 | 40 | 18 | $15K |
| Xdemvy Lotilaner | 30 | 49 | 30 | $55K |
| Xiidra Lifitegrast | 24 | 24 | Under 11 | $16K |
| Dexamethasone Sodium Phosphate Generic | 21 | 23 | 14 | $714 |
| Restasis Cyclosporine | 18 | 24 | Under 11 | $15K |
| Loteprednol Etabonate Generic | 17 | 18 | 12 | $2,232 |
| Miebo Perfluorohexyloctane/Pf | 17 | 17 | Under 11 | $12K |
| Lumigan Bimatoprost | 15 | 20 | Under 11 | $5,067 |
| Cequa Cyclosporine | 14 | 14 | Under 11 | $7,892 |
| Acyclovir Generic | 13 | 13 | Under 11 | $126 |
| Timolol Maleate Generic | 11 | 20 | Under 11 | $68.71 |
Brand drugs: 259 claims; generic drugs: 304 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mackenzie Macintyre III $271 ($271 in general payments such as food, travel and fees) from 6 companies. The largest payer was Oyster Point Pharma, Inc. with $72.55.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.